NEW YORK, April 17 (Reuters) - U.S. regulators approved a dose of the osteoporosis drug Actonel that will allow patients to take one tablet on two consecutive days, for a total of two tablets monthly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results